DEBORAH BARNES: Open Payments
NPI 1114223690 · BRUNSWICK, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$833 in 43 payments from 12 companies in 2025. Trend: 2023 $1,018 · 2024 $1,241 · 2025 $833
Food & beverage: $833
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $278 |
| Janssen Biotech, Inc. | 11 | $192 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $107 |
| Gilead Sciences, Inc. | 2 | $46 |
| PFIZER INC. | 2 | $44 |
| Regeneron Healthcare Solutions, Inc. | 1 | $35 |
| Ipsen Biopharmaceuticals, Inc | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
| Aimmune Therapeutics, Inc. | 1 | $24 |
| Madrigal Pharmaceuticals | 1 | $23 |
Products named: TREMFYA, CREON, ENTYVIO, MAVYRET, VELSIPITY, RINVOQ, DUPIXENT, LINZESS.
Industry payments across GA — which companies pay providers there.
